199 related articles for article (PubMed ID: 31063704)
1. Soluble klotho regulates TRPC6 calcium signaling
Wright JD; An SW; Xie J; Lim C; Huang CL
FASEB J; 2019 Aug; 33(8):9182-9193. PubMed ID: 31063704
[TBL] [Abstract][Full Text] [Related]
2. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
Wright JD; An SW; Xie J; Yoon J; Nischan N; Kohler JJ; Oliver N; Lim C; Huang CL
FASEB J; 2017 Aug; 31(8):3574-3586. PubMed ID: 28442546
[TBL] [Abstract][Full Text] [Related]
3. Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.
Dalton G; An SW; Al-Juboori SI; Nischan N; Yoon J; Dobrinskikh E; Hilgemann DW; Xie J; Luby-Phelps K; Kohler JJ; Birnbaumer L; Huang CL
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):752-757. PubMed ID: 28069944
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
[TBL] [Abstract][Full Text] [Related]
5. Munc13 mediates klotho-inhibitable diacylglycerol-stimulated exocytotic insertion of pre-docked TRPC6 vesicles.
Xie J; An SW; Jin X; Gui Y; Huang CL
PLoS One; 2020; 15(3):e0229799. PubMed ID: 32134975
[TBL] [Abstract][Full Text] [Related]
6. FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction.
Smith ER; Holt SG; Hewitson TD
Int J Biochem Cell Biol; 2017 Nov; 92():63-78. PubMed ID: 28919046
[TBL] [Abstract][Full Text] [Related]
7. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
[TBL] [Abstract][Full Text] [Related]
8. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
[TBL] [Abstract][Full Text] [Related]
9. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
Erben RG
Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
[TBL] [Abstract][Full Text] [Related]
10. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
11. Regulation of fibroblast growth factor-23 signaling by klotho.
Kurosu H; Ogawa Y; Miyoshi M; Yamamoto M; Nandi A; Rosenblatt KP; Baum MG; Schiavi S; Hu MC; Moe OW; Kuro-o M
J Biol Chem; 2006 Mar; 281(10):6120-3. PubMed ID: 16436388
[TBL] [Abstract][Full Text] [Related]
12. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
13. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23, klotho and heparin.
Thomas SM; Li Q; Faul C
Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):313-323. PubMed ID: 37195242
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization.
Shalhoub V; Ward SC; Sun B; Stevens J; Renshaw L; Hawkins N; Richards WG
Calcif Tissue Int; 2011 Aug; 89(2):140-50. PubMed ID: 21633782
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of Klotho binding to fibroblast growth factor 23 prevents hypophosphetemia.
Fakhar M; Rashid S
J Mol Graph Model; 2017 Aug; 75():9-19. PubMed ID: 28501532
[TBL] [Abstract][Full Text] [Related]
17. FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho.
Suzuki Y; Kuzina E; An SJ; Tome F; Mohanty J; Li W; Lee S; Liu Y; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31800-31807. PubMed ID: 33257569
[TBL] [Abstract][Full Text] [Related]
18. Klotho converts canonical FGF receptor into a specific receptor for FGF23.
Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T
Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194
[TBL] [Abstract][Full Text] [Related]
19. Structural asymmetry in FGF23 signaling.
Liu SH; Xiao Z; Smith JC; Quarles LD
Trends Pharmacol Sci; 2023 Dec; 44(12):862-864. PubMed ID: 37778940
[TBL] [Abstract][Full Text] [Related]
20. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
